{"id":"https://openalex.org/W1998296189","doi":"https://doi.org/10.1097/qai.0b013e31818a657c","title":"Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection: A Substudy of the ANRS 106 Window Trial","display_name":"Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection: A Substudy of the ANRS 106 Window Trial","publication_year":2008,"publication_date":"2008-11-13","ids":{"openalex":"https://openalex.org/W1998296189","doi":"https://doi.org/10.1097/qai.0b013e31818a657c","mag":"1998296189","pmid":"https://pubmed.ncbi.nlm.nih.gov/18931625"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0b013e31818a657c","doi":"https://doi.org/10.1097/qai.0b013e31818a657c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e31818a657c","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091340151","display_name":"Isabelle Charreau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Isabelle Charreau","raw_affiliation_strings":["INSERM SC10, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM SC10, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108618474","display_name":"Gr\u00e9goire Jeanblanc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gr\u00e9goire Jeanblanc","raw_affiliation_strings":["Department of Public Health, Henri Mondor Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health, Henri Mondor Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France","institution_ids":["https://openalex.org/I4210097159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037346966","display_name":"Philippe Tangre","orcid":"https://orcid.org/0009-0003-9924-9075","observed_orcids":["https://orcid.org/0009-0003-9924-9075"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Philippe Tangre","raw_affiliation_strings":["INSERM SC10, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM SC10, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111612438","display_name":"L. Boyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence Boyer","raw_affiliation_strings":["Brabois Hospital, Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brabois Hospital, Nancy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007994313","display_name":"Marine Saouzanet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Marine Saouzanet","raw_affiliation_strings":["INSERM SC10, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM SC10, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043909607","display_name":"Bruno Marchou","orcid":"https://orcid.org/0000-0002-0673-2945","observed_orcids":["https://orcid.org/0000-0002-0673-2945"]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bruno Marchou","raw_affiliation_strings":["Purpan Hospital, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Purpan Hospital, Toulouse, France","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046238828","display_name":"Jean\u2010Michel Molina","orcid":"https://orcid.org/0000-0001-8684-2214","observed_orcids":["https://orcid.org/0000-0001-8684-2214","https://orcid.org/0000-0002-6711-8754"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean Michel Molina","raw_affiliation_strings":["St Louis Hospital, Assistance Publique-Hospitaux de Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Louis Hospital, Assistance Publique-Hospitaux de Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111802779","display_name":"Jean Pierre Aboulker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean Pierre Aboulker","raw_affiliation_strings":["INSERM SC10, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM SC10, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065617907","display_name":"Isabelle Durand\u2010Zaleski","orcid":"https://orcid.org/0000-0002-4078-1476","observed_orcids":["https://orcid.org/0000-0002-4078-1476"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Isabelle Durand-Zaleski","raw_affiliation_strings":["Department of Public Health, Henri Mondor Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health, Henri Mondor Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France","institution_ids":["https://openalex.org/I4210097159"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5007994313","https://openalex.org/A5037346966","https://openalex.org/A5091340151","https://openalex.org/A5111802779"],"corresponding_institution_ids":["https://openalex.org/I154526488"],"apc_list":null,"apc_paid":null,"fwci":0.4435,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.66115702,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"49","issue":"4","first_page":"416","last_page":"421"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.7064999938011169,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.7064999938011169,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.16760000586509705,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.04309999942779541,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intermittent-antiretroviral-therapy","display_name":"intermittent antiretroviral therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/structured-treatment-interruption","display_name":"structured treatment interruption","score":0.890999972820282},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7110000252723694},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6179999709129333},{"id":"https://openalex.org/keywords/cost-analysis","display_name":"cost analysis","score":0.5389999747276306},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8544790744781494},{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.5953586101531982},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5309441089630127},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.5185614228248596},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.45063018798828125},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4137651324272156},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4126228392124176},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3999418616294861},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3678276240825653},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.302858829498291},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.1877213716506958},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12199726700782776},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/qai.0b013e31818a657c","doi":"https://doi.org/10.1097/qai.0b013e31818a657c","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e31818a657c","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:18931625","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18931625","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1497170016","https://openalex.org/W1984746979","https://openalex.org/W2016156911","https://openalex.org/W2034763538","https://openalex.org/W2051589825","https://openalex.org/W2077500974","https://openalex.org/W2108719992","https://openalex.org/W2117150863","https://openalex.org/W2124815803","https://openalex.org/W2126633107","https://openalex.org/W2129630483","https://openalex.org/W2153327514"],"related_works":["https://openalex.org/W2001492441","https://openalex.org/W2073424749","https://openalex.org/W2034337080","https://openalex.org/W2126633107","https://openalex.org/W2039284756","https://openalex.org/W1976292095","https://openalex.org/W2090781817","https://openalex.org/W4210285994","https://openalex.org/W4413413924","https://openalex.org/W2070384357"],"abstract_inverted_index":{"BACKGROUND:":[0],"Structured":[1],"treatment":[2,129,136,312],"interruptions":[3],"in":[4,51,61,224,229,236,252,258,271,279,284,296,310],"chronic":[5],"HIV":[6],"infection":[7],"have":[8],"been":[9],"explored":[10],"as":[11],"a":[12,28,46,57,65,73,94,106,122,145,262,293,311],"drug-sparing":[13],"strategy":[14,314],"to":[15,32,72,119,121,132,268,321],"reduce":[16],"drug-related":[17],"adverse":[18,322],"events":[19,323],"and":[20,44,105,192,195,198,227],"costs":[21,181,276,319],"while":[22],"maintaining":[23],"CD4":[24,96,107,146],"cell":[25,147],"counts":[26],"at":[27,114],"level":[29],"high":[30],"enough":[31],"prevent":[33],"the":[34,42,49,62,170,173,176,185,199,225,230,242,253,259,269,280,285,297,306,318],"risk":[35],"of":[36,64,98,141,172,245,290,300],"disease":[37],"progression.":[38],"OBJECTIVES:":[39],"To":[40],"test":[41],"hypothesis":[43],"put":[45],"figure":[47],"on":[48,127,209],"reduction":[50,295],"total":[52,298],"medical":[53],"costs,":[54],"we":[55],"conducted":[56],"cost":[58,215,235,299,307],"study":[59,68,178],"analysis":[60],"setting":[63],"randomized":[66],"open-label":[67],"comparing":[69],"an":[70,210],"intermittent":[71,128],"continuous":[74],"antiretroviral":[75,90],"regimen.":[76],"PATIENTS":[77],"AND":[78],"METHODS:":[79],"Four":[80],"hundred":[81],"three":[82],"HIV-1-infected":[83],"adults":[84],"who":[85,143],"were":[86,116,160,167,182,207,217],"tolerating":[87],"highly":[88],"active":[89],"therapy":[91],"(HAART),":[92],"with":[93],"nadir":[95],"count":[97,108,148],"100":[99],"cells":[100,111,151],"per":[101,112,152,239],"microliter":[102,113,153],"or":[103,131,324],"more":[104],"above":[109],"450":[110],"screening,":[115],"randomly":[117],"assigned":[118],"switch":[120],"fixed":[123],"8-week":[124,126],"off,":[125],"(IT)":[130],"maintain":[133],"their":[134],"current":[135],"(CT)":[137],"strategy.":[138],"The":[139,233,288],"proportions":[140],"patients":[142,221,223],"reached":[144],"below":[149],"300":[150],"through":[154],"96":[155,243],"weeks":[156,244],"(primary":[157],"end":[158],"point)":[159],"not":[161,316],"significantly":[162],"different":[163],"between":[164],"arms.":[165],"Costs":[166],"estimated":[168],"from":[169,184],"viewpoint":[171],"payer":[174],"over":[175,241],"96-week":[177],"period.":[179],"Unit":[180],"provided":[183],"national":[186,200],"reimbursement":[187],"schedules":[188],"for":[189,203,219],"hospital":[190],"inpatient":[191],"outpatient":[193],"admissions":[194],"ambulatory":[196],"visits":[197],"selling":[201],"price":[202],"medications.":[204],"All":[205],"analyses":[206],"performed":[208],"intention-to-treat":[211],"basis.":[212],"RESULTS:":[213],"Complete":[214],"data":[216],"available":[218],"391":[220],"(197":[222],"IT":[226,254,281,291],"194":[228],"CT":[231,260,286],"arms).":[232],"mean":[234],"euros":[237],"(Euro)":[238],"patient":[240],"follow-up":[246],"(excluding":[247],"protocol-driven":[248,275],"costs)":[249],"was":[250],"9738":[251],"arm":[255],"vs.":[256,282],"16,162":[257],"arm,":[261],"6424":[263],"difference":[264,270],"almost":[265],"entirely":[266],"due":[267],"HAART":[272],"cost.":[273],"Mean":[274],"represented":[277],"Euro290":[278],"Euro280":[283],"arm.":[287],"use":[289],"achieved":[292],"40%":[294,305],"HAART.":[301],"CONCLUSIONS:":[302],"Reducing":[303],"by":[304],"ofHAART":[308],"medications":[309],"interruption":[313],"did":[315],"increase":[317],"related":[320],"consultations.":[325]},"counts_by_year":[{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}